Relation of gallbladder function and Helicobacter pylori infection to gastric mucosa inflammation in patients with symptomatic cholecystolithiasis

Digestion
Panos StathopoulosDieter Jungst

Abstract

Inflammatory alterations of the gastric mucosa are commonly caused by Helicobacter pylori (Hp) infection in patients with symptomatic gallstone disease. However, the additional pathogenetic role of an impaired gallbladder function leading to an increased alkaline duodenogastric reflux is controversially discussed. To investigate the relation of gallbladder function and Hp infection to gastric mucosa inflammation in patients with symptomatic gallstones prior to cholecystectomy. Seventy-three patients with symptomatic gallstones were studied by endoscopy and Hp testing. Gastritis classification was performed according to the updated Sydney System and gallbladder function was determined by total lipid concentration of gallbladder bile collected during mainly laparoscopic cholecystectomy. Fifteen patients revealed no, 39 patients mild, and 19 moderate to marked gastritis. No significant differences for bile salts, phospholipids, cholesterol, or total lipids in gallbladder bile were found between these three groups of patients. However, while only 1 out of 54 (<2%) patients with mild or no gastritis was found histologically positive for Hp, this infection could be detected in 14 (74%) out of 19 patients with moderate to marked gastr...Continue Reading

References

Nov 1, 1992·The British Journal of Surgery·B M UreH Sommer
Dec 1, 1991·Scandinavian Journal of Gastroenterology·J KellosaloS Laitinen
Mar 30, 1991·BMJ : British Medical Journal·R JohnsenP G Burhol
Feb 1, 1990·Annals of Surgery·J CabrolR Segura
Dec 7, 1989·The New England Journal of Medicine·C P DooleyM J Blaser
Jan 1, 1989·American Journal of Surgery·T H BrownG M Larson
Apr 1, 1987·Scandinavian Journal of Gastroenterology·S NiemeläJ Lehtola
Aug 1, 1987·Gastroenterology·P BechiL Tonelli
Aug 1, 1987·Scandinavian Journal of Gastroenterology·H HyvärinenM Kekki
Apr 1, 1986·Gastrointestinal Endoscopy·K AkdamarJ Ryan
Mar 1, 1986·Scandinavian Journal of Gastroenterology·J O SvenssonJ Svanvik
May 1, 1986·Journal of Clinical Pathology·M F DixonD Johnston
Jun 1, 1984·Gastrointestinal Endoscopy·A EmmanouilidisO Manousos
Feb 1, 1982·The British Journal of Surgery·C R MackieA Cuschieri
Jan 1, 1995·Irish Journal of Medical Science·M T CaldwellT P Hennessy
Dec 25, 2002·Digestive Diseases and Sciences·Martin FeinKarl-Hermann Fuchs
Dec 10, 2003·Journal of Clinical Microbiology·Cíntia Presser SilvaDulciene Maria Magalhães Queiroz

❮ Previous
Next ❯

Citations

Jun 11, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·M Shirin SabbaghianPeter Shamamian
Sep 1, 2008·Gut and Liver·Ariel A BensonJames Aisenberg
May 25, 2010·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·M Shirin SabbaghianPeter Shamamian
Jun 6, 2020·Microorganisms·Irina N Grigor'eva, Tatyana I Romanova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
Vildan TaşkinBülent Kantarçeken
Roczniki Akademii Medycznej W Białymstoku = Annales Academiae Medicae Bialostocensis
A Vdovychenko
Archives of Disease in Childhood
A SzarszewskiP Lass
© 2022 Meta ULC. All rights reserved